» Articles » PMID: 38677282

Modeling Type 1 Diabetes Progression Using Machine Learning and Single-cell Transcriptomic Measurements in Human Islets

Overview
Journal Cell Rep Med
Publisher Cell Press
Date 2024 Apr 27
PMID 38677282
Authors
Affiliations
Soon will be listed here.
Abstract

Type 1 diabetes (T1D) is a chronic condition in which beta cells are destroyed by immune cells. Despite progress in immunotherapies that could delay T1D onset, early detection of autoimmunity remains challenging. Here, we evaluate the utility of machine learning for early prediction of T1D using single-cell analysis of islets. Using gradient-boosting algorithms, we model changes in gene expression of single cells from pancreatic tissues in T1D and non-diabetic organ donors. We assess if mathematical modeling could predict the likelihood of T1D development in non-diabetic autoantibody-positive donors. While most autoantibody-positive donors are predicted to be non-diabetic, select donors with unique gene signatures are classified as T1D. Our strategy also reveals a shared gene signature in distinct T1D-associated models across cell types, suggesting a common effect of the disease on transcriptional outputs of these cells. Our study establishes a precedent for using machine learning in early detection of T1D.

Citing Articles

Interferon-α promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic β-cells.

Carre A, Samassa F, Zhou Z, Perez-Hernandez J, Lekka C, Manganaro A Nat Commun. 2025; 16(1):765.

PMID: 39824805 PMC: 11748642. DOI: 10.1038/s41467-025-55908-9.


Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.

Shapiro M, Tallon E, Brown M, Posgai A, Clements M, Brusko T Diabetologia. 2024; 68(3):477-494.

PMID: 39694914 PMC: 11832708. DOI: 10.1007/s00125-024-06339-6.


Integrating Molecular Perspectives: Strategies for Comprehensive Multi-Omics Integrative Data Analysis and Machine Learning Applications in Transcriptomics, Proteomics, and Metabolomics.

Sanches P, de Melo N, M Porcari A, de Carvalho L Biology (Basel). 2024; 13(11).

PMID: 39596803 PMC: 11592251. DOI: 10.3390/biology13110848.

References
1.
Guo H, Li J . scSorter: assigning cells to known cell types according to marker genes. Genome Biol. 2021; 22(1):69. PMC: 7898451. DOI: 10.1186/s13059-021-02281-7. View

2.
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141. PMC: 8454663. DOI: 10.1016/j.xinn.2021.100141. View

3.
Doncheva N, Morris J, Gorodkin J, Jensen L . Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J Proteome Res. 2018; 18(2):623-632. PMC: 6800166. DOI: 10.1021/acs.jproteome.8b00702. View

4.
Bluestone J, Buckner J, Herold K . Immunotherapy: Building a bridge to a cure for type 1 diabetes. Science. 2021; 373(6554):510-516. DOI: 10.1126/science.abh1654. View

5.
Kharchenko P, Silberstein L, Scadden D . Bayesian approach to single-cell differential expression analysis. Nat Methods. 2014; 11(7):740-2. PMC: 4112276. DOI: 10.1038/nmeth.2967. View